The First Easy-To-Use, FDA- Approved ERP/qEEG Device
1 in 4 Patients With Cognitive Disorders Is Misdiagnosed.
Shepherd Healthcare Solutions Untangles The Uncertainties.
![Shephed Healthcare Solutions](https://static.wixstatic.com/media/c1f00b_3b9ed4bd532f465a9cabad4b705cc2ed~mv2.jpg/v1/fill/w_1022,h_400,al_c,q_85,enc_auto/7fca5add4e86eb0c3439ca8db209643b.jpg)
Our Cognitive Test is FDA Approved. It is an objective biomarker system offering clarity in a field of complexity by facilitating an objective evaluation of patients with cognitive disorders.
![peyronies-disease-treatment-doctor.jpg](https://static.wixstatic.com/media/c1f00b_6c91f076c4e949ee9986fec699219b4d~mv2.jpg/v1/crop/x_0,y_0,w_1536,h_1014/fill/w_106,h_70,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/peyronies-disease-treatment-doctor.jpg)
Shepherd Healthcare Solutions assists neurologists and other physicians to
effectively differentiate between dementia and depression, track disease progression and assess overall cognitive deficits associated with dementia and concussion/mTBI.
-
Differentiating dementia from depression
-
Detecting deficits in the brain early in the disease process
-
Tracking disease progression over time
-
Demonstrating medications are working
-
Facilitating better return to environment decisions post head injury
-
Predicting disease course and outcome after a concussion or TBI